20 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

Miragen Therapeutics, Inc. MGEN shares rose 31.96% to $1.24 during Wednesday's pre-market session.

Venus Concept, Inc. VERO stock increased by 19.75% to $4.85. According to the most recent rating by Oppenheimer, on Mar 31, the current rating is at Perform.

Fulgent Genetics, Inc. FLGT stock increased by 15.27% to $19.02. The most recent rating by BTIG, on May 29, is at Buy, with a price target of $20.

FSD Pharma, Inc. HUGE shares moved upwards by 10.60% to $4.80.

electroCore, Inc. ECOR stock increased by 10.59% to $1.07. The most recent rating by H.C. Wainwright, on Mar 24, is at Buy, with a price target of $2.

CTI BioPharma, Inc. CTIC shares rose 9.65% to $1.25.

Millendo Therapeutics, Inc. MLND stock rose 8.82% to $2.59. The most recent rating by Citigroup, on May 29, is at Buy, with a price target of $6.

ContraFect, Inc. CFRX stock increased by 7.51% to $6.73. The most recent rating by Cantor Fitzgerald, on Jun 9, is at Overweight, with a price target of $15.

Heat Biologics, Inc. HTBX stock increased by 7.44% to $0.82.

Moleculin Biotech, Inc. MBRX shares rose 7.34% to $1.17.

 

Losers

Chembio Diagnostics, Inc. CEMI shares fell 56.70% to $4.30 during Wednesday's pre-market session. The most recent rating by Canaccord Genuity, on Jun 17, is at Hold, with a price target of $7.

BioCardia, Inc. BCDA stock declined 18.97% to $2.35.

AVEO Pharmaceuticals, Inc. AVEO shares decreased by 13.60% to $5.40. The most recent rating by HC Wainwright & Co., on May 1, is at Buy, with a price target of $10.

Edesa Biotech, Inc. EDSA stock declined 9.37% to $6.

Brickell Biotech, Inc. BBI shares declined 8.82% to $1.55.

Xenetic Biosciences, Inc. XBIO stock declined 6.72% to $1.11.

Aphria, Inc. APHA shares fell 5.80% to $4.22.

Seneca Biopharma, Inc. SNCA stock fell 5.17% to $0.81.

China SXT Pharmaceuticals, Inc. SXTC stock fell 5.06% to $0.45.

Radius Health, Inc. RDUS shares fell 5.01% to $12.51. The most recent rating by Morgan Stanley, on May 13, is at Equal-Weight, with a price target of $20.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversTrading IdeasHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!